July 5, 2024 11:00 AM EDT
News Briefing

In­novent re­works deal with IA­SO; Gran­za rais­es $7M

ENDPOINTS

Plus, news about Kvan­ti­fy:

Chi­na’s In­novent takes a stake in CAR-T part­ner: Af­ter bring­ing the BC­MA CAR-T ther­a­py Fu­ca­so to mar­ket in Chi­na, In­novent and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

RSV vac­cines off to a slug­gish start in US this sea­son, with vol­umes be­hind 2023

Biotech's third quar­ter was rel­a­tive­ly bright — with a few caveats

EMA re­views hair loss prod­ucts fol­low­ing con­cerns about sui­ci­dal thoughts

J&J dis­con­tin­ues mid-stage dengue study, cit­ing de­pri­or­i­ti­za­tion of com­mu­ni­ca­ble dis­ease work

Sanofi sells rare dis­ease drug En­jay­mo to Recor­dati for $825M up­front

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times